Pharmaceutical compositions of 5,7,14-triazatetracyclo[10.3.1.0(2,11).0(4,9)]-hexadeca-2(11)3,5,7,9-pentaene

Pharmaceutical compositions of 5,7,14-triazatetracyclo[10.3.1.0(2,11).0(4,9)]-hexadeca-2(11)3,5,7,9-pentaene

  • CN 1,596,128 A
  • Filed: 11/04/2002
  • Published: 03/16/2005
  • Est. Priority Date: 11/30/2001
  • Status: Active Application
First Claim
Patent Images

1. be suitable for controlled release form, comprise 5,8,14-three azepine Fourth Ring [10.3.1.0 curee'"'"'s administration 2,11.0 4,9]-16 carbon-2 (11) 3,5,7,9-pentaene or its pharmaceutically acceptable salt and being lower than about 6mg/ hour speed to the doser of described chemical compound of described curee'"'"'s administration or salt, thus administration is at least about the described chemical compound of 0.1mg or its pharmaceutically acceptable salt in 24 hour time limit.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×